MAETZOLD DEREK J sold CSTL

April 6, 2026 · Form 4 insider transaction

MAETZOLD DEREK J sold 6,214 shares of Castle Biosciences, Inc. at $25.03 per share, a transaction worth $155.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
6,214
Price
$25.03
Total value
$155.5K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 6, 2026
Filing dateApril 8, 2026
Shares owned after21,479
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 3, 2025.; This transaction was executed in multiple trades at prices ranging from $24.64 to $25.29, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR
MAETZOLD DEREK J sold CSTL: April 6, 2026 | Insider Trading Screener